首页> 美国卫生研究院文献>Filaria Journal >Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation
【2h】

Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation

机译:以消除疟疾为目标的牛:使用缓释伊维菌素植入物制剂可显着降低阿拉伯按蚊存活六个月以上

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMosquitoes that feed on animals can survive and mediate residual transmission of malaria even after most humans have been protected with insecticidal bednets or indoor residual sprays. Ivermectin is a widely-used drug for treating parasites of humans and animals that is also insecticidal, killing mosquitoes that feed on treated subjects. Mass administration of ivermectin to livestock could be particularly useful for tackling residual malaria transmission by zoophagic vectors that evade human-centred approaches. Ivermectin comes from a different chemical class to active ingredients currently used to treat bednets or spray houses, so it also has potential for mitigating against emergence of insecticide resistance. However, the duration of insecticidal activity obtained with ivermectin is critical to its effectiveness and affordability.
机译:背景技术以动物为食的蚊子即使在大多数人受到杀虫蚊帐或室内残留喷雾剂保护后,仍可以生存并介导疟疾的残留传播。伊维菌素是一种广泛用于治疗人类和动物寄生虫的药物,也具有杀虫作用,杀死以治疗对象为食的蚊子。伊维菌素对家畜的大量施用可能特别有用,可通过以人为中心的食虫性媒介解决残留的疟疾传播。伊维菌素与当前用于治疗蚊帐或喷房的活性成分的化学类别不同,因此也具有缓解抗药性的潜力。但是,用伊维菌素获得的杀虫活性的持续时间对其有效性和可承受性至关重要。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号